SIMULATIONS PLUS

Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide... Simulations Plus, Inc. (NASDAQ GSM: SLP) is the leading developer of modeling and simulation software for the pharmaceutical and biotechnology industries today. Our software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research & development costs and helping clients make better project decisions… sooner... We provide validated machine learning, QSP, QST, HTPK, PBPK, and PBBM..

Also known as: Simulation